about
Comparison of oral microbiota in tumor and non-tumor tissues of patients with oral squamous cell carcinomaOral tongue cancer gene expression profiling: Identification of novel potential prognosticators by oligonucleotide microarray analysis.The role of novel oncogenes squamous cell carcinoma-related oncogene and phosphatidylinositol 3-kinase p110alpha in squamous cell carcinoma of the oral tongue.Molecular profiling of oral microbiota in jawbone samples of bisphosphonate-related osteonecrosis of the jaw.Systematic review of laser and other light therapy for the management of oral mucositis in cancer patients.Effects of therapy on dentofacial development in long-term survivors of head and neck rhabdomyosarcoma: the memorial sloan-kettering cancer center experience.Osteonecrosis of the jaw in cancer patients receiving IV bisphosphonates.Radiographic osteoradionecrosis of the jaw with intact mucosa: Proposal of clinical guidelines for early identification of this conditionOsteonecrosis of the jaw in patients treated with denosumab for metastatic tumors to the bone: A series of thirteen patients.Osteonecrosis of the jaw a new complication related to Ipilimumab.Serum N-telopeptide and bone-specific alkaline phosphatase levels in patients with osteonecrosis of the jaw receiving bisphosphonates for bone metastases.Downregulation of Fanconi anemia genes in sporadic head and neck squamous cell carcinoma.Intraoral angiosarcoma: treatment with a brachytherapy prosthesis.Intravenous bisphosphonate-related osteonecrosis of the jaw: long-term follow-up of 109 patients.Osteonecrosis of the maxilla and mandible in patients with advanced cancer treated with bisphosphonate therapy.Gene expression profiling allows distinction between primary and metastatic squamous cell carcinomas in the lung.Correlation of osteoradionecrosis and dental events with dosimetric parameters in intensity-modulated radiation therapy for head-and-neck cancerLeft parotid mass in a 71-year-old womanDosimetric distribution to the tooth-bearing regions of the mandible following intensity-modulated radiation therapy for base of tongue cancerOsteonecrosis of the Jaw Related to Bevacizumab
P50
Q30528676-28436446-4D59-442B-ADDC-210043F6D525Q33399279-FD2F4220-BFAD-4F27-B8E4-BAA7F704A32FQ34204445-8D1F74CD-0905-41A5-A024-A56F9C6037FAQ34207408-66ADDFCC-28C9-4E48-8FF7-3F02189C24F6Q34419150-017262E8-4265-4BA5-B9DC-A3C240281B88Q35079479-9CDC0FDB-5814-45A5-8E1D-21FF68A030BAQ36598626-A600A86F-FF44-4754-AEC7-2821E8C17E82Q36667396-1EF196DA-3944-4D2A-B94C-42172BB71AE5Q36667402-C5E147AB-6C7C-4256-9449-B64E6E02FBADQ38865775-DCDDA082-E5E6-425B-83FA-90DF053C7BB5Q39652919-CAAF1F78-8C68-4687-985C-92C59A3B6C2AQ40149078-79D9754F-C0EA-4DA4-8FF5-EFB12C54277FQ41245917-31AE709E-4F66-4837-B8B3-561F90B03BF1Q44838120-A0B91DF9-0479-4571-AE21-A443D1EE36FAQ46434749-7E805F8B-6C8E-461C-AA41-0010B0BC4DC0Q51976099-EAAEEE4C-53B1-44C0-902E-9A7D203F2074Q56658594-87FD1316-5EB0-4DD6-999D-FD5F9236D144Q60386671-ABC5D53C-9A26-421F-840E-7F38EA9DB455Q60386733-4F6CF272-9A07-4AEF-94EF-4F42CD098260Q60386785-A46B7B99-7BEB-494E-81E4-497DAD6ED224
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Cherry L Estilo
@ast
Cherry L Estilo
@en
Cherry L Estilo
@es
Cherry L Estilo
@nl
Cherry L Estilo
@sl
type
label
Cherry L Estilo
@ast
Cherry L Estilo
@en
Cherry L Estilo
@es
Cherry L Estilo
@nl
Cherry L Estilo
@sl
prefLabel
Cherry L Estilo
@ast
Cherry L Estilo
@en
Cherry L Estilo
@es
Cherry L Estilo
@nl
Cherry L Estilo
@sl
P106
P21
P31
P496
0000-0003-2802-0671
P569
2000-01-01T00:00:00Z